SAGIT for Classification of Patients With Acromegaly in Clinical Practice
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
The purpose of this pilot study is to test SAGIT (Signs and symptoms - Associated
 comorbidities - GH concentration level - IGF-1 - Tumour). SAGIT is a Clinician-Reported
 Outcomes (ClinROs) tool developed to describe patients with acromegaly. This study will
 determine the potential use of a finalised operational version for patient classification in
 clinical practice and studies.

 In addition, this study intends to carry out a qualitative evaluation of the acceptability of
 SAGIT by the practicing endocrinologist in terms of relevance, ease of use, applicability and
 usefulness of the tool in practice.
Inclusion Criteria:

 -  Male or female aged 18 years-old or above

 -  Patient with diagnosis of acromegaly with the presence of pituitary adenoma, elevated
 IGF-1 and lack of serum GH suppression after oral glucose tolerance test (OGTT)

 -  Controlled/stable, active and treatment naïve patients.

 -  Patient with the cognitive and linguistic capacities to understand the information
 letter of the study

 -  Patient who signed informed consent

 Exclusion Criteria:

 -  History of non-compliance or inability to reliably receive treatment in the
 foreseeable future

 -  Gaps in treatment of greater than 1 month within the 12 months prior to study entry